- Release Date: 13/05/25 14:06
- Summary: NEU receives FDA minutes and re-confirms Phase 3 endpoints
- Price Sensitive: No
- Download Document 161.63KB
- Forums
- ASX - By Stock
- NEU
- Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.84%
!
$20.03

Ann: NEU receives FDA minutes and re-confirms Phase 3 endpoints
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$20.03 |
Change
-0.170(0.84%) |
Mkt cap ! $2.551B |
Open | High | Low | Value | Volume |
$20.19 | $20.19 | $19.87 | $822.5K | 41.07K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31 | $20.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.03 | 74 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 131 | 19.950 |
5 | 135 | 19.940 |
4 | 129 | 19.930 |
4 | 70 | 19.920 |
2 | 180 | 19.910 |
Price($) | Vol. | No. |
---|---|---|
19.980 | 141 | 5 |
19.990 | 152 | 4 |
20.000 | 434 | 8 |
20.010 | 580 | 3 |
20.020 | 260 | 3 |
Last trade - 10.18am 10/09/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |